These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36408162)

  • 1. Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.
    Mancini A; Colapietro A; Cristiano L; Rossetti A; Mattei V; Gravina GL; Perez-Montoyo H; Yeste-Velasco M; Alfon J; Domenech C; Festuccia C
    Front Oncol; 2022; 12():943064. PubMed ID: 36408162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.
    Muñoz-Guardiola P; Casas J; Megías-Roda E; Solé S; Perez-Montoyo H; Yeste-Velasco M; Erazo T; Diéguez-Martínez N; Espinosa-Gil S; Muñoz-Pinedo C; Yoldi G; Abad JL; Segura MF; Moran T; Romeo M; Bosch-Barrera J; Oaknin A; Alfón J; Domènech C; Fabriàs G; Velasco G; Lizcano JM
    Autophagy; 2021 Jun; 17(6):1349-1366. PubMed ID: 32397857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
    Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E; Pérez-Montoyo H; Alfon J; Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodríguez-Freixinos V; Lizcano JM; Domènech C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
    Gynecol Oncol; 2019 May; 153(2):425-435. PubMed ID: 30853360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
    López-Plana A; Fernández-Nogueira P; Muñoz-Guardiola P; Solé-Sánchez S; Megías-Roda E; Pérez-Montoyo H; Jauregui P; Yeste-Velasco M; Gómez-Ferreria M; Erazo T; Ametller E; Recalde-Percaz L; Moragas-Garcia N; Noguera-Castells A; Mancino M; Morán T; Nadal E; Alfón J; Domènech C; Gascon P; Lizcano JM; Fuster G; Bragado P
    Int J Cancer; 2020 Aug; 147(4):1163-1179. PubMed ID: 31943158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase.
    Erazo T; Lorente M; López-Plana A; Muñoz-Guardiola P; Fernández-Nogueira P; García-Martínez JA; Bragado P; Fuster G; Salazar M; Espadaler J; Hernández-Losa J; Bayascas JR; Cortal M; Vidal L; Gascón P; Gómez-Ferreria M; Alfón J; Velasco G; Domènech C; Lizcano JM
    Clin Cancer Res; 2016 May; 22(10):2508-19. PubMed ID: 26671995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis.
    París-Coderch L; Soriano A; Jiménez C; Erazo T; Muñoz-Guardiola P; Masanas M; Antonelli R; Boloix A; Alfón J; Pérez-Montoyo H; Yeste-Velasco M; Domènech C; Roma J; Sánchez de Toledo J; Moreno L; Lizcano JM; Gallego S; Segura MF
    Cell Death Dis; 2020 Sep; 11(9):773. PubMed ID: 32943619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.
    Vidal L; Victoria I; Gaba L; Martín MG; Brunet M; Colom H; Cortal M; Gómez-Ferrería M; Yeste-Velasco M; Perez A; Rodon J; Sohal DPS; Lizcano JM; Domènech C; Alfón J; Gascón P
    Eur J Cancer; 2021 Mar; 146():87-94. PubMed ID: 33588149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma.
    Peñaranda Fajardo NM; Meijer C; Kruyt FA
    Biochem Pharmacol; 2016 Oct; 118():1-8. PubMed ID: 27106078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
    Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response.
    Matteoni S; Matarrese P; Ascione B; Ricci-Vitiani L; Pallini R; Villani V; Pace A; Paggi MG; Abbruzzese C
    J Exp Clin Cancer Res; 2021 Nov; 40(1):347. PubMed ID: 34740374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
    Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
    Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres.
    Oh HC; Shim JK; Park J; Lee JH; Choi RJ; Kim NH; Kim HS; Moon JH; Kim EH; Chang JH; Yook JI; Kang SG
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2817-2828. PubMed ID: 32712753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Glioblastoma Stem Cells with 2-Deoxy-D-Glucose (2-DG) Potentiates Radiation-Induced Unfolded Protein Response (UPR).
    Shah SS; Rodriguez GA; Musick A; Walters WM; de Cordoba N; Barbarite E; Marlow MM; Marples B; Prince JS; Komotar RJ; Vanni S; Graham RM
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30709011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel
    Sansalone L; Veliz EA; Myrthil NG; Stathias V; Walters W; Torrens II; Schürer SC; Vanni S; Leblanc RM; Graham RM
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.